---
title: "Beyond Automation: How AI Transforms Clinical Evaluation Reports into Strategic Regulatory Assets"
date: "2025-09-11T11:53:59.000Z"
publishedDate: "11 septembre 2025"
summary: "Some manufacturers are now embedding CER processes within broader regulatory operating systems, integrating authoring, surveillance, and quality management to enable real-time adaptability. Artificial Intelligence (AI) , in particular, is playing an increasingly critical role in helping manufacturers meet expanding regulatory expectations."
importance: ""
sourceUrl: "https://medtechintelligence.com/feature_article/beyond-automation-how-ai-transforms-clinical-evaluation-reports-into-strategic-regulatory-assets/"
tags: ["France", "Actualité", "MedTech Intelligence"]
permalink: "/papers/2025-09-11-beyond-automation-how-ai-transforms-clinical-evaluation-reports-into-strategic-regulatory-assets"
imageUrl: "https://medtechintelligence.com/wp-content/uploads/2025/09/AI-Driven-CERs.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://medtechintelligence.com/feature_article/beyond-automation-how-ai-transforms-clinical-evaluation-reports-into-strategic-regulatory-assets/"
---

![Beyond Automation: How AI Transforms Clinical Evaluation Reports into Strategic Regulatory Assets](https://medtechintelligence.com/wp-content/uploads/2025/09/AI-Driven-CERs.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://medtechintelligence.com/feature_article/beyond-automation-how-ai-transforms-clinical-evaluation-reports-into-strategic-regulatory-assets/*

## L’essentiel

Some manufacturers are now embedding CER processes within broader regulatory operating systems, integrating authoring, surveillance, and quality management to enable real-time adaptability. Artificial Intelligence (AI) , in particular, is playing an increasingly critical role in helping manufacturers meet expanding regulatory expectations.

## Lien source

https://medtechintelligence.com/feature_article/beyond-automation-how-ai-transforms-clinical-evaluation-reports-into-strategic-regulatory-assets/
